ClearPoint Neuro Inc. (CLPT)

NASDAQ: CLPT · IEX Real-Time Price · USD
9.00
-0.13 (-1.42%)
At close: Jan 21, 2022 4:00 PM
8.85
-0.15 (-1.67%)
After-hours:Jan 21, 2022 7:49 PM EST
Market Cap212.76M
Revenue (ttm)15.73M
Net Income (ttm)-11.84M
Shares Out23.64M
EPS (ttm)-0.61
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume274,745
Open9.00
Previous Close9.13
Day's Range8.82 - 9.42
52-Week Range8.82 - 31.29
Beta0.97
AnalystsStrong Buy
Price Target32.00 (+255.6%)
Earnings Daten/a

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, ...

IndustryHealth Care Equipment & Supplies
Founded1998
Employees67
Stock ExchangeNASDAQ
Ticker SymbolCLPT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for CLPT stock is "Strong Buy" and the 12-month stock price forecast is 32.00.

Price Target
$32.00
(255.56% upside)
Analyst Consensus: Strong Buy

News

ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference

SOLANA BEACH, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

2 weeks ago - GlobeNewsWire

ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the ...

SOLANA BEACH, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

2 months ago - GlobeNewsWire

ClearPoint Neuro Reports Third Quarter 2021 Results

Record Revenue Achieved; Company Reaffirms 2021 Revenue Forecast Record Revenue Achieved; Company Reaffirms 2021 Revenue Forecast

2 months ago - GlobeNewsWire

ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Foc...

SOLANA BEACH, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

2 months ago - GlobeNewsWire

Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of D...

SOLANA BEACH, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

2 months ago - GlobeNewsWire

ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021

SOLANA BEACH, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

2 months ago - GlobeNewsWire

ClearPoint Neuro Stock Dives After Q2 Earnings

ClearPoint Neuro Inc (NASDAQ: CLPT) reported Q2 revenue of $3.4 million, a 38% Y/Y increase, below the consensus estimate of $3.68 million. Functional neurosurgery navigation revenue increased 74% to $1...

5 months ago - Benzinga

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Lags Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of -21.43% and -1.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Recap: ClearPoint Neuro Q2 Earnings

Shares of ClearPoint Neuro (NASDAQ:CLPT) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 54.55% year over year to ($0.17), which m...

5 months ago - Benzinga

ClearPoint Neuro Reports Second Quarter 2021 Results

Record Case Volume Supported Clinically During the Quarter Record Case Volume Supported Clinically During the Quarter

5 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor m...

SOLANA BEACH, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced ...

5 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. (CLPT) Stock Jumps 9.8%: Will It Continue to Soar?

ClearPoint Neuro, Inc. (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...

5 months ago - Zacks Investment Research

2 Stocks that could 10X in 10 years

If you are a growth investor, there is nothing more tantalizing than finding a company that could potentially grow by ten times or more in the future.

Other symbols:ASTS
5 months ago - The Dog of Wall Street

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical ...

SOLANA BEACH, Calif. and SALT LAKE CITY, July 21, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and deli...

6 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

6 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland

SOLANA BEACH, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced ...

7 months ago - GlobeNewsWire

ClearPoint Neuro Set to Join Russell 3000® Index

SOLANA BEACH, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, ...

7 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patie...

First Ever Stem Cell Clinical Trial Patient Treated Using Entire ClearPoint Platform First Ever Stem Cell Clinical Trial Patient Treated Using Entire ClearPoint Platform

7 months ago - GlobeNewsWire

ClearPoint Neuro to Present at the UBS Global Healthcare Virtual Conference

SOLANA BEACH, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, a...

8 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software

SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing navigation and delivery to the brain, today anno...

8 months ago - GlobeNewsWire

ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array'

SOLANA BEACH, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, t...

8 months ago - GlobeNewsWire

ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and O...

SOLANA BEACH, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, t...

8 months ago - GlobeNewsWire

Earnings Preview: ClearPoint Neuro, Inc. (CLPT) Q1 Earnings Expected to Decline

ClearPoint Neuro, Inc. (CLPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021

SOLANA BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...

8 months ago - GlobeNewsWire

ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candid...

SOLANA BEACH, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...

8 months ago - GlobeNewsWire